Adequate timing of thromboembolic prophylaxis in colorectal cancer surgery

Authors

  • Ghada Morshed Department of Surgery, Faculty of Medicine Fayoum University, Fayoum, University, Cairo, Egypt
  • Nader Zaki Department of Surgery, Faculty of Medicine Fayoum University, Fayoum, University, Cairo, Egypt

DOI:

https://doi.org/10.18203/2349-2902.isj20180355

Keywords:

Bleeding complications, Colorectal cancer, Thromboembolic prophylaxis

Abstract

Background: It has been found that patients with colorectal cancer are at increased risk for postoperative venous thromboembolism. The aim of this prospective study is to evaluate the incidence of venous thromboembolism and major bleeding complications in patients undergoing colorectal cancer who are treated with preoperative or postoperative venous thromboprophylaxis.

Methods: This prospective study included 30 patients from September 2013 to November 2017. There were 22 males and 8 females; mean age was 66.7±5.5 years (range 44-78). Author divided the patients randomly into two groups (group A=15 cases with preoperative and group B = 15 cases with postoperative venous thromboprophylaxis).

Results: There was no significant difference in preoperative versus postoperative thromboembolic prophylaxis regarding postoperative DVT 0/15(0%) vs 1/15 (6.6%), P=0.69, no bleeding complications and no pulmonary embolism.

Conclusions: Preoperative and postoperative thromboembolic prophylaxis are equally safe in venous thromboembolism protection. 

References

Gould MK, Garcia DA, Wren SM. Prevention of VTE in non-orthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th Ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e227S-77.

Merrill A, Millham F. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease. Arch Surg. 2012;147:120-4.

Sweetland S, Green J, Liu B. Million Women Study Collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583.

Bergqvist D, Agnelli G, Cohen AT. Enoxacan II Investigators, Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975-80.

Vedovati MC, Becattini C, Rondelli F. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259(4):665-9.

McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, et al. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg. 2001;233(3):438.

Heit JA, O'Fallon WM, Petterson TM. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: A population-based study. Arch Intern Med. 2002;162:1245-8.

Agnelli G, Bolis G, Capussotti L. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243(1):89-95.

Monn MF, Haut ER, Lau BD. Is venous thromboembolism in colorectal surgery patients preventable or inevitable? One institution’s experience. J Am Coll Surg. 2013;216(3):395-401.

Fleming FJ, Kim MJ, Salloum RM. How much do we need to worry about venous thromboembolism after hospital discharge? a study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum. 2010;53(10):1355-60.

Henke PK, Arya S, Pannucci C. Procedure-specific venous thromboembolism prophylaxis: a paradigm from colectomy surgery. Surg. 2012;152(4):528-34.

Shapiro R, Vogel JD, Kiran RP. Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum. 2011;54(12):1496-502.

Greenblatt DY, Rajamanickam V, Pugely AJ. Short-term outcomes after laparoscopic-assisted proctectomy for rectal cancer: results from the ACS NSQIP. J Am Coll Surg. 2011;212(5):844-54.

Sulu B, Aytac E, Stocchi L, Vogel JD. The minimally invasive approach is associated with reduced perioperative thromboembolic and bleeding complications for patients receiving preoperative chronic oral anticoagulant therapy who undergo colorectal surgery. Surg Endosc. 2013;27(4):1339-45.

Merkow RP, Bilimoria KY, McCarter MD. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208(1):53-61.

Mustain WC, Davenport DL, Hourigan JS Obesity and laparoscopic colectomy: outcomes from the ACS-NSQIP database. Dis Colon Rectum. 2012;55(4):429-35.

Kakkar VV, Balibrea JL, Martínez-González J CANBESURE Study Group. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost. 2010;8(6):1223-9.

Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol. 2007;14(2):929-36.

Zaghiyan KN, Sax HC, Miraflor E. Timing of Chemical Thromboprophylaxis and Deep Vein Thrombosis in Major Colorectal Surgery: A Randomized Clinical Trial. Ann Surg. 2016;264(4):632-9.

Steve Kwon. Meissner M. Rebecca Symons. J Am Coll Surg. 2011;213:596-603.

Bergqvist D. Venous Thromboembolism: A review of risk and prevention in colorectal surgery patients. Dis Colon Rectum. 2006;49(10):1620-8.

Downloads

Published

2018-01-25

Issue

Section

Original Research Articles